Twitter/X et Bluesky
06/07/2021
Laurent Mottron, Michelle Dawson (2013). The autistic spectrum. Handbook of Clinical Neurology, 111, 263-271. Elsevier.
Lien vers la source citée05/07/2021
1 réponse intégrée de Michelle Dawson
05/07/2021 14:14
Notes: 17% (12/72) of the PR-ESSENCE group dropped out, vs 3% (1/36) of controls. Trial started in March 2014 but wasn't registered until Dec 2018, see https://t.co/hukKWEDIiO & the name "PR-ESSENCE" did not appear in the trial registration until 2020, after study completion
Voir la réponse sur Twitter/XGöteborg University (2014). PR-ESSENCE for Youth With Challenging Behavior. ClinicalTrials.gov. Göteborg University.
Lien vers la source citéeMats Johnson, Carina Gillberg, Ingrid Vinsa, Gunnar Fransson, Lena Samuelsson, Klara Jakobsson, Sven Östlund, Elisabeth Fernell, et al. (2023). A randomized controlled trial of a new intervention in early symptomatic syndromes eliciting neurodevelopmental clinical examinations: PR-ESSENCE. European Child & Adolescent Psychiatry, 32(1), 63-74. Springer Science and Business Media LLC.
Lien vers la source citée05/07/2021
Carolien Torenvliet, Annabeth Groenman, Tulsi Radhoe, Joost Agelink van Rentergem, Wikke van der Putten, Hilde Geurts (2021). Parallel Age-Related Cognitive Effects in Autism: A Cross-Sectional Replication Study. Center for Open Science.
Lien vers la source citée04/07/2021
NORCE Norwegian Research Centre AS, University of Bergen, University of Vienna (2021). Music for Autism (M4A). ClinicalTrials.gov. NORCE Norwegian Research Centre AS.
Lien vers la source citée04/07/2021
(n.d.). https://www.canlii.org/en/on/onhrt/doc/2021/2021hrto499/2021hrto499.html
Lien vers la source citée03/07/2021
Michael J Hurley, Robert M J Deacon, A W Edith Chan, David Baker, David L Selwood, Patricia Cogram (2022). Reversal of behavioural phenotype by the cannabinoid-like compound VSN16R in fragile X syndrome mice. Brain, 145(1), 76-82. Oxford University Press (OUP).
Lien vers la source citée03/07/2021
Liron Rozenkrantz, Anila M. D’Mello, John D.E. Gabrieli (2021). Enhanced rationality in autism spectrum disorder. Trends in Cognitive Sciences, 25(8), 685-696. Elsevier BV.
Lien vers la source citée02/07/2021
Ruud Hortensius, Michaela Kent, Kohinoor M. Darda, Laura Jastrzab, Kami Koldewyn, Richard Ramsey, Emily S. Cross (2021). Exploring the relationship between anthropomorphism and theory‐of‐mind in brain and behaviour. Human Brain Mapping, 42(13), 4224-4241. Wiley.
Lien vers la source citée02/07/2021
2 réponses intégrées de Michelle Dawson
02/07/2021 01:48
Note: among participants providing specific motivations for their substance use, 39.6% of autistics vs 66% of non-autistics reported "social motivations"
Voir la réponse sur Twitter/X02/07/2021 03:55
And: there's a related commentary https://t.co/l2BfLMOs38 "although autistic people are generally less likely to use substances than non-autistic people, when they do, they might do so for very different & more maladaptive reasons"?
Voir la réponse sur Twitter/XLucy Anne Livingston (2021). Substance use, coping, and compensation in autism. The Lancet Psychiatry, 8(8), 641-642. Elsevier BV.
Lien vers la source citéeElizabeth Weir, Carrie Allison, Simon Baron-Cohen (2021). Understanding the substance use of autistic adolescents and adults: a mixed-methods approach. The Lancet Psychiatry, 8(8), 673-685. Elsevier BV.
Lien vers la source citée01/07/2021
Catherine L. Caldwell-Harris (2021). An Explanation for Repetitive Motor Behaviors in Autism: Facilitating Inventions via Trial-and-Error Discovery. Frontiers in Psychiatry, 12, 657774-657774. Frontiers Media SA.
Lien vers la source citée